Shares soar in Chinese drugmaker after positive COVID drug trials

Fatigue after COVID is way more than just feeling tired. Five tips on what to do about it
6 April 2022
How the ‘test to treat’ initiative aims to get ahead of the next wave of COVID-19
6 April 2022

Shares soar in Chinese drugmaker after positive COVID drug trials

Shares in the Chinese pharmaceutical group Kintor rocketed on Wednesday after it reported that trials had shown its COVID-19 drug to be highly effective, making it potentially China’s first homegrown antiviral treatment.

Comments are closed.